Skip to main content
Clinical Trials/NCT04058938
NCT04058938
Completed
N/A

A Randomized Control Trial of Patient Education on Pain Control in Breast Surgery

University of Kansas Medical Center1 site in 1 country100 target enrollmentMarch 1, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Opioid Use
Sponsor
University of Kansas Medical Center
Enrollment
100
Locations
1
Primary Endpoint
Opioid consumption
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study will be a randomized control trial providing an educational component to study participants and a pre-operative and post-operative survey with a goal to show an improvement in pain control, decrease in narcotic use, and increase in patient knowledge in the study group.

Detailed Description

The use of opioid pain medications in surgical patients is contributing to an epidemic of opioid pain medication use. It is known that the quality of pain control after surgery is a large factor of the patient's perception of their experience. However, little research has been done to improve pain control in plastic surgery patients. To the investigators knowledge, no study has yet looked at education of breast surgery patients to improve pain experience. The study goal is to survey breast surgery patients in the Plastic Surgery department before and after surgery to evaluate the participants experience with pain and pain medications. Half of the participants in the study will be randomized to receive an information sheet about pain control at the participants pre-operative appointment.

Registry
clinicaltrials.gov
Start Date
March 1, 2018
End Date
March 1, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Katie Egan

Plastic Surgery Resident

University of Kansas Medical Center

Eligibility Criteria

Inclusion Criteria

  • Female patients presenting for the first stage of breast reconstruction using tissue expanders
  • Patients 18 years of age and older

Exclusion Criteria

  • Male patients
  • Patients under age 18
  • Patients who have had previous breast reconstruction or tissue expansion
  • Patients who are not able to read English will be excluded from this study as the study materials will be in written English

Outcomes

Primary Outcomes

Opioid consumption

Time Frame: 1-2 weeks

Opioid consumption will be calculated from patient report of remaining narcotics at the postoperative appointment and the total opioid amount prescribed, from the medical record.

Secondary Outcomes

  • Pain control: survey(1-2 weeks)

Study Sites (1)

Loading locations...

Similar Trials